This company has been marked as potentially delisted and may not be actively trading. Seagen (SGEN) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock SGEN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Pfizer raises guidance as COVID franchise drives Q3 beatOctober 30, 2024 | seekingalpha.comPfizer Delivers Knockout Q3 Earnings Results, But Investors Are UnimpressedOctober 30, 2024 | seekingalpha.comFranklin Biotechnology Discovery COctober 5, 2024 | morningstar.comMPfizer: Turning The Corner (Rating Upgrade)May 27, 2024 | seekingalpha.comTwo Brothers, a Big Biotech Bet and an $8 Billion PayoutApril 13, 2024 | wsj.comRon Baron Portfolio Magic: Building Your Financial FutureMarch 20, 2024 | msn.comBailouts are back, Fed outlook reassessed, Pfizer M&A - what's moving marketsMarch 13, 2024 | msn.comPfizer shutting down Seagen's $350M construction project in EverettMarch 1, 2024 | bizjournals.comNeuralink’s First Brain Implant Patient Can Control Mouse with Thoughts, Musk SaysFebruary 24, 2024 | finance.yahoo.comMRNA Feb 2024 64.000 putFebruary 23, 2024 | finance.yahoo.comMRNA Feb 2024 77.000 callFebruary 23, 2024 | finance.yahoo.comPfizer adds bull at Guggenheim on ex-COVID prospectsFebruary 23, 2024 | msn.comMRNA Feb 2024 67.000 putFebruary 22, 2024 | finance.yahoo.comPfizer touts cancer efforts in first Super Bowl commercialFebruary 12, 2024 | msn.comPRIMECAP Management's Strategic Exits and New Positions Highlight Q4 MovesFebruary 10, 2024 | finance.yahoo.comPfizer Q4 results on deck amid gloomy earnings outlookJanuary 29, 2024 | msn.comPro Research: Wall Street eyes Seagen's growth trajectoryJanuary 28, 2024 | za.investing.comAllspring Global Investments Holdings LLC Lowers Stake in Seagen Inc. (NASDAQ:SGEN)January 16, 2024 | marketbeat.comYelin Lapidot Holdings Management Ltd. Makes New $5.22 Million Investment in Seagen Inc. (NASDAQ:SGEN)January 13, 2024 | marketbeat.comOregon Public Employees Retirement Fund Has $3.41 Million Position in Seagen Inc. (NASDAQ:SGEN)January 12, 2024 | marketbeat.comING Groep NV Lowers Stock Holdings in Seagen Inc. (NASDAQ:SGEN)January 11, 2024 | marketbeat.comSGEN Jan 2024 210.000 putDecember 30, 2023 | ca.finance.yahoo.comSGEN Jan 2024 235.000 put(CONTRDecember 30, 2023 | ca.finance.yahoo.comSGEN Dec 2023 195.000 put(CONTRDecember 29, 2023 | uk.finance.yahoo.comPro Research: Wall Street dives into Seagen's oncology advancesDecember 27, 2023 | za.investing.comHBM Gets Health Boost From Drug Licensing DealsDecember 22, 2023 | seekingalpha.comPfizer Shares Slump After Waning Covid Sales Hurt 2024 OutlookDecember 14, 2023 | msn.comPfizer: From pandemic hero to investor jitters (SGEN)Pfizer's transitions from pandemic success to market concerns: analyzing revenue stagnation, investor reactions, and the company's strategic roadmap for growth.December 14, 2023 | marketbeat.comSeagen (Nasdaq:SGEN) HeadlineTrading was temporarily halted for "SGEN" at 07:12 PM with a stated reason of "News pending."...December 14, 2023 | marketbeat.comTake-Two Interactive Software to replace Seagen on Nasdaq-100 IndexDecember 13, 2023 | seekingalpha.comPfizer to Establish New Oncology Division Following Completion of Seagen DealDecember 13, 2023 | msn.comPfizer slips as 2024 guidance with Seagen buyout disappointsDecember 13, 2023 | msn.comGTS Securities LLC Makes New $14.89 Million Investment in Seagen Inc. (NASDAQ:SGEN)December 13, 2023 | marketbeat.comPolar Asset Management Partners Inc. Makes New $12.92 Million Investment in Seagen Inc. (NASDAQ:SGEN)December 12, 2023 | marketbeat.comPfizer gets OK for $43-bln Seagen deal after donating cancer drug rightsDecember 12, 2023 | nasdaq.comWhat the Options Market Tells Us About SeagenDecember 11, 2023 | benzinga.comSeagen Inc. (NASDAQ:SGEN) Shares Acquired by Hudson Bay Capital Management LPDecember 11, 2023 | marketbeat.com88% of patients with advanced stage classical Hodgkin Lymphoma in trial remained progression free at 24 months –December 10, 2023 | businesswire.comADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy Combination Delivers 100% Progression Free Survival at 12 months in Phase 2 Trial of Patients with Early Stage Classical Hodgkin LymphomaDecember 10, 2023 | finance.yahoo.comCanyon Capital Advisors LLC Makes New $20.47 Million Investment in Seagen Inc. (NASDAQ:SGEN)December 10, 2023 | marketbeat.comA Closer Look at Seagen's Options Market DynamicsDecember 8, 2023 | benzinga.comMarshall Wace LLP Grows Stock Holdings in Seagen Inc. (NASDAQ:SGEN)December 8, 2023 | marketbeat.com$100 Invested In Seagen 20 Years Ago Would Be Worth This Much TodayDecember 7, 2023 | benzinga.comSeagen's breast cancer drug shows positive results in combination therapy trialDecember 6, 2023 | msn.comSeagen: HER2CLIMB-02 Study Results Reinforce Clinical Activity Of TUKYSADecember 6, 2023 | markets.businessinsider.comTUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast CancerDecember 6, 2023 | finance.yahoo.comSeagen gains amid options trades, optimism for FTC approval for Pfizer dealDecember 5, 2023 | msn.comPolar Capital Holdings Plc Reduces Stock Holdings in Seagen Inc. (NASDAQ:SGEN)December 3, 2023 | marketbeat.comSeagen Stock (NASDAQ:SGEN), Guidance and ForecastDecember 3, 2023 | benzinga.comWhy Is Seattle Genetics (SGEN) Down 0.7% Since Last Earnings Report?December 1, 2023 | finance.yahoo.com Get Seagen News Delivered to You Automatically Sign up to receive the latest news and ratings for SGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address SGEN Media Mentions By Week SGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SGEN News Sentiment▼0.001.01▲Average Medical News Sentiment SGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SGEN Articles This Week▼00▲SGEN Articles Average Week Get Seagen News Delivered to You Automatically Sign up to receive the latest news and ratings for SGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Vertex Pharmaceuticals News Regeneron Pharmaceuticals News Alnylam Pharmaceuticals News Biogen News United Therapeutics News Incyte News Neurocrine Biosciences News Exelixis News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SGEN) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Seagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
